A Phase 3b, Randomized, Single-Blind, Controlled, Comparative Efficacy and Safety Study of Topical Fibrocaps (Raplixa) and Tachosil in Surgical Hemostasis during Hepatic Resection

Trial Profile

A Phase 3b, Randomized, Single-Blind, Controlled, Comparative Efficacy and Safety Study of Topical Fibrocaps (Raplixa) and Tachosil in Surgical Hemostasis during Hepatic Resection

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Aug 2017

At a glance

  • Drugs Fibrinogen/thrombin (Primary)
  • Indications Surgical blood loss
  • Focus Registrational; Therapeutic Use
  • Acronyms Finish 3b
  • Sponsors ProFibrix; The Medicines Company
  • Most Recent Events

    • 30 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 31 Jul 2015 Status changed from active, no longer recruiting to recruiting as per ClinicalTrials.gov record.
    • 28 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top